SIBIA to file Parkinson's therapy IND in late 1996/early 1997 -- IPO prospectus.
Executive Summary
SIBIA TO FILE PARKINSON's THERAPY IND IN LATE 1996/EARLY 1997, a "red herring" prospectus for the La Jolla, Calif.-based company's initial public offering reports. SIBIA Neurosciences (formerly the Salk Institute Biotechnology/Industrial Associates) is seeking a corporate partner for the compound, SIB-1508Y, which exhibits subtype-selective nicotinic acetylcholine receptor agonist activity.